Patrick Hsu on AI, Biotech, and the Future of Science

Описание: What happens when a CRISPR pioneer, biotech investor, and AI futurist shares one brain?

In this episode of RNAi Revolution, we discuss a recent Slack interview with Patrick Hsu—co-founder of the Arc Institute and early member of the Editas team—and explore the fast-evolving intersection of artificial intelligence and life sciences.

We discuss Hsu's reflections on what’s changed (and what hasn’t) in biotech company strategy, the promise and limits of AI in drug discovery, and what it will take to bring the next wave of foundational science to life.

Topics include:

-AI-designed lifeforms and digital cell models
-Lessons from Editas and the rise of gene editing
-Angel investing in biotech
-Why GLP-1s reshaped pharma priorities
-Building better institutions for science

Not investment advice. Do your own due diligence.

🔬 More at    / @rnairevolution